Weinreb Robert N, Khaw Peng Tee
Hamilton Glaucoma Center and Department of Ophthalmology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946, USA.
Lancet. 2004 May 22;363(9422):1711-20. doi: 10.1016/S0140-6736(04)16257-0.
Primary open-angle glaucoma is a progressive optic neuropathy and, perhaps, the most common form of glaucoma. Because the disease is treatable, and because the visual impairment caused by glaucoma is irreversible, early detection is essential. Early diagnosis depends on examination of the optic disc, retinal nerve fibre layer, and visual field. New imaging and psychophysical tests can improve both detection and monitoring of the progression of the disease. Recently completed long-term clinical trials provide convincing evidence that lowering intraocular pressure prevents progression at both the early and late stages of the disease. The degree of protection is related to the degree to which intraocular pressure is lowered. Improvements in therapy consist of more effective and better-tolerated drugs to lower intraocular pressure, and more effective surgical procedures. New treatments to directly treat and protect the retinal ganglion cells that are damaged in glaucoma are also in development.
原发性开角型青光眼是一种进行性视神经病变,可能也是最常见的青光眼类型。由于该疾病可治,且青光眼所致的视力损害不可逆转,因此早期检测至关重要。早期诊断依赖于对视盘、视网膜神经纤维层和视野的检查。新的成像和心理物理学测试可改善疾病的检测及进展监测。近期完成的长期临床试验提供了令人信服的证据,表明降低眼压可预防疾病早期和晚期的进展。保护程度与眼压降低的程度相关。治疗方面的改进包括更有效且耐受性更好的降低眼压药物,以及更有效的手术方法。直接治疗和保护青光眼受损视网膜神经节细胞的新疗法也在研发中。